208 related articles for article (PubMed ID: 21673516)
1. PML-RARα enhances constitutive autophagic activity through inhibiting the Akt/mTOR pathway.
Huang Y; Hou JK; Chen TT; Zhao XY; Yan ZW; Zhang J; Yang J; Kogan SC; Chen GQ
Autophagy; 2011 Oct; 7(10):1132-44. PubMed ID: 21673516
[TBL] [Abstract][Full Text] [Related]
2. Skp2 promotes APL progression through the stabilization of oncoprotein PML-RARα and the inhibition of JunB expression.
Dan W; Zhong L; Yu L; Xiong L; Li J; Ye J; Luo X; Liu C; Chu X; Liu B
Life Sci; 2022 Jan; 289():120231. PubMed ID: 34921867
[TBL] [Abstract][Full Text] [Related]
3. Autophagy regulates myeloid cell differentiation by p62/SQSTM1-mediated degradation of PML-RARα oncoprotein.
Wang Z; Cao L; Kang R; Yang M; Liu L; Zhao Y; Yu Y; Xie M; Yin X; Livesey KM; Tang D
Autophagy; 2011 Apr; 7(4):401-11. PubMed ID: 21187718
[TBL] [Abstract][Full Text] [Related]
4. Caspases mediate retinoic acid-induced degradation of the acute promyelocytic leukemia PML/RARalpha fusion protein.
Nervi C; Ferrara FF; Fanelli M; Rippo MR; Tomassini B; Ferrucci PF; Ruthardt M; Gelmetti V; Gambacorti-Passerini C; Diverio D; Grignani F; Pelicci PG; Testi R
Blood; 1998 Oct; 92(7):2244-51. PubMed ID: 9746761
[TBL] [Abstract][Full Text] [Related]
5. PIC-1/SUMO-1-modified PML-retinoic acid receptor alpha mediates arsenic trioxide-induced apoptosis in acute promyelocytic leukemia.
Sternsdorf T; Puccetti E; Jensen K; Hoelzer D; Will H; Ottmann OG; Ruthardt M
Mol Cell Biol; 1999 Jul; 19(7):5170-8. PubMed ID: 10373566
[TBL] [Abstract][Full Text] [Related]
6. Targeting the acute promyelocytic leukemia-associated fusion proteins PML/RARα and PLZF/RARα with interfering peptides.
Beez S; Demmer P; Puccetti E
PLoS One; 2012; 7(11):e48636. PubMed ID: 23152790
[TBL] [Abstract][Full Text] [Related]
7. MEK inhibition induces caspases activation, differentiation blockade and PML/RARalpha degradation in acute promyelocytic leukaemia.
Barbarroja N; Siendones E; Torres LA; Luque MJ; Martinez JM; Dorado G; Velasco F; Torres A; López-Pedrera C
Br J Haematol; 2008 Jul; 142(1):27-35. PubMed ID: 18445086
[TBL] [Abstract][Full Text] [Related]
8. The PML/RARalpha fusion protein inhibits tumor necrosis factor-alpha-induced apoptosis in U937 cells and acute promyelocytic leukemia blasts.
Testa U; Grignani F; Samoggia P; Zanetti C; Riccioni R; Lo Coco F; Diverio D; Felli N; Passerini CG; Grell M; Pelicci PG; Peschle C
J Clin Invest; 1998 May; 101(10):2278-89. PubMed ID: 9593784
[TBL] [Abstract][Full Text] [Related]
9. PML-RARα interaction with TRIB3 impedes PPARγ/RXR function and triggers dyslipidemia in acute promyelocytic leukemia.
Li K; Wang F; Yang ZN; Cui B; Li PP; Li ZY; Hu ZW; Zhu HH
Theranostics; 2020; 10(22):10326-10340. PubMed ID: 32929351
[TBL] [Abstract][Full Text] [Related]
10. Reduced retinoic acid-sensitivities of nuclear receptor corepressor binding to PML- and PLZF-RARalpha underlie molecular pathogenesis and treatment of acute promyelocytic leukemia.
Guidez F; Ivins S; Zhu J; Söderström M; Waxman S; Zelent A
Blood; 1998 Apr; 91(8):2634-42. PubMed ID: 9531570
[TBL] [Abstract][Full Text] [Related]
11. PML-RARα stabilized by zinc in human acute promyelocytic leukemia NB4 cells.
Zhu B; Wang JY; Zhou JJ; Zhou F; Cheng W; Liu YT; Wang J; Chen X; Chen DH; Luo L; Hua ZC
J Inorg Biochem; 2017 Oct; 175():92-100. PubMed ID: 28743050
[TBL] [Abstract][Full Text] [Related]
12. PML-RAR alpha induces the downmodulation of HHEX: a key event responsible for the induction of an angiogenetic response.
Saulle E; Petronelli A; Pelosi E; Coppotelli E; Pasquini L; Ilari R; Lo-Coco F; Testa U
J Hematol Oncol; 2016 Apr; 9():33. PubMed ID: 27052408
[TBL] [Abstract][Full Text] [Related]
13. TRIB3 Promotes APL Progression through Stabilization of the Oncoprotein PML-RARα and Inhibition of p53-Mediated Senescence.
Li K; Wang F; Cao WB; Lv XX; Hua F; Cui B; Yu JJ; Zhang XW; Shang S; Liu SS; Yu JM; Han MZ; Huang B; Zhang TT; Li X; Jiang JD; Hu ZW
Cancer Cell; 2017 May; 31(5):697-710.e7. PubMed ID: 28486108
[TBL] [Abstract][Full Text] [Related]
14. Deregulation of NPM and PLZF in a variant t(5;17) case of acute promyelocytic leukemia.
Hummel JL; Wells RA; Dubé ID; Licht JD; Kamel-Reid S
Oncogene; 1999 Jan; 18(3):633-41. PubMed ID: 9989813
[TBL] [Abstract][Full Text] [Related]
15. Annexin A2-S100A10 heterotetramer is upregulated by PML/RARα fusion protein and promotes plasminogen-dependent fibrinolysis and matrix invasion in acute promyelocytic leukemia.
Huang D; Yang Y; Sun J; Dong X; Wang J; Liu H; Lu C; Chen X; Shao J; Yan J
Front Med; 2017 Sep; 11(3):410-422. PubMed ID: 28687976
[TBL] [Abstract][Full Text] [Related]
16. Retinoic acid (RA) and As2O3 treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML-RARalpha and PLZF-RARalpha oncoproteins.
Rego EM; He LZ; Warrell RP; Wang ZG; Pandolfi PP
Proc Natl Acad Sci U S A; 2000 Aug; 97(18):10173-8. PubMed ID: 10954752
[TBL] [Abstract][Full Text] [Related]
17. In vitro inhibition of promyelocytic leukemia/retinoic acid receptor-alpha (PML/RARalpha) expression and leukemogenic activity by DNA/LNA chimeric antisense oligos.
Caprodossi S; Galluzzi L; Biagetti S; Della Chiara G; Pelicci PG; Magnani M; Fanelli M
Oncol Res; 2005; 16(3):157-66. PubMed ID: 16925116
[TBL] [Abstract][Full Text] [Related]
18. Two critical hits for promyelocytic leukemia.
He LZ; Bhaumik M; Tribioli C; Rego EM; Ivins S; Zelent A; Pandolfi PP
Mol Cell; 2000 Nov; 6(5):1131-41. PubMed ID: 11106752
[TBL] [Abstract][Full Text] [Related]
19. Distinct leukemia phenotypes in transgenic mice and different corepressor interactions generated by promyelocytic leukemia variant fusion genes PLZF-RARalpha and NPM-RARalpha.
Cheng GX; Zhu XH; Men XQ; Wang L; Huang QH; Jin XL; Xiong SM; Zhu J; Guo WM; Chen JQ; Xu SF; So E; Chan LC; Waxman S; Zelent A; Chen GQ; Dong S; Liu JX; Chen SJ
Proc Natl Acad Sci U S A; 1999 May; 96(11):6318-23. PubMed ID: 10339585
[TBL] [Abstract][Full Text] [Related]
20. Identification of B94 (TNFAIP2) as a potential retinoic acid target gene in acute promyelocytic leukemia.
Rusiniak ME; Yu M; Ross DT; Tolhurst EC; Slack JL
Cancer Res; 2000 Apr; 60(7):1824-9. PubMed ID: 10766166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]